Clinical significance of serum clusterin as a biomarker for evaluating diagnosis and metastasis potential of viral-related hepatocellular carcinoma

Clinical Biochemistry
Abeer M NafeeNaglaa A Mostafa

Abstract

Hepatocellular carcinoma (HCC) is an increasing problem in Egypt. Clusterin has been reported to play a significant role in tumorigenesis. The aim of this study is to evaluate clusterin as a marker for evaluating diagnosis and metastasis potential of viral-related HCC. Eighty patients with HCC, 30 patients with liver cirrhosis, 30 patients with chronic hepatitis and 30 healthy controls were enrolled in study. Estimation of serum clusterin was done by enzyme linked immunosorbent assay. Serum clusterin levels were significantly increased in patients with HCC. Serum clusterin was highly increased in patients with poorly differentiated tumor, capsular infiltration, portal vein invasion and lymph node infiltration. Receiver operator characteristic curve showed that clusterin had a greater area under curve value (0.95) than that of alpha fetoprotein (0.85). At cutoff value of 128 μg/mL, serum clusterin yielded (90%) sensitivity and (87%) specificity for predicting HCC. We concluded that clusterin is a promising useful marker for diagnosis of HCC. Clusterin might be deemed as a useful marker for predicting the progression and metastasis potential of HCC.

References

Feb 1, 1994·The Journal of Clinical Investigation·L E FrenchJ A Schifferli
Oct 13, 1999·Seminars in Liver Disease·J M LlovetJ Bruix
Jan 13, 2001·Gut·J Bruix, J M Llovet
Mar 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jean-Nicolas VautheyDavid M Nagorney
Mar 22, 2002·The International Journal of Biochemistry & Cell Biology·Steve E Jones, Catherine Jomary
Nov 18, 2003·International Journal of Cancer. Journal International Du Cancer·Maurizio ScaltritiSaverio Bettuzzi
Feb 3, 2004·Oncogene·Sabina PucciLuigi Giusto Spagnoli
Apr 13, 2004·Oncogene·Dick D Mosser, Richard I Morimoto
Jan 26, 2005·Human Pathology·Yun Kyung KangWoo Ho Kim
Mar 12, 2005·CA: a Cancer Journal for Clinicians·D Max ParkinPaola Pisani
Sep 20, 2005·Molecular Biotechnology·Niels GregersenPeter Bross
Oct 27, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN Practice Guidelines Committee, American Association for the Study of Liver Diseases
Jul 21, 2006·Molecular & Cellular Proteomics : MCP·Ana M Rodríguez-PiñeiroFrancisco J Rodríguez-Berrocal

❮ Previous
Next ❯

Citations

Oct 3, 2012·The Lancet Oncology·Jung-Fa TsaiWan-Long Chuang
Feb 9, 2016·International Journal of Cancer. Journal International Du Cancer·Cun WangWenxin Qin
Feb 18, 2016·Journal of Cancer Research and Therapeutics·Eman A BayomiAyman M Metwally
Apr 2, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Hatem A El-mezayen, Hossam Darwish
Dec 17, 2016·Expert Opinion on Therapeutic Targets·Mark R Wilson, Amina Zoubeidi
May 5, 2017·Anti-cancer Drugs·Marilina García-ArandaMaximino Redondo
Jul 12, 2016·Biomarkers in Cancer·Ranjit Chauhan, Nivedita Lahiri
May 25, 2016·International Journal of Cancer. Journal International Du Cancer·Idoia Ortega-MartínezMaría D Boyano
Oct 1, 2019·Journal of the Chinese Medical Association : JCMA·Po-Chung KuoGar-Yang Chau
Jul 4, 2019·Neurotoxicity Research·Alika SarkarMahendra Pratap Singh
Oct 28, 2019·Veterinary and Comparative Oncology·Katie A McNaughtMark McLaughlin
Jan 21, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wenjie ZhengDengfu Yao
Jul 29, 2015·World Journal of Gastroenterology : WJG·Peng XiuJie Li
Aug 13, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Wenjie ZhengDengfu Yao
Dec 5, 2019·Journal of the Chinese Medical Association : JCMA·Po-Chung KuoGar-Yang Chau
Oct 13, 2016·World Journal of Gastroenterology : WJG·Stijn Van HeesThomas Vanwolleghem

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis